Company Information

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE539.504.25 (+0.79 %)
PREV CLOSE ( ) 535.25
OPEN PRICE ( ) 540.00
BID PRICE (QTY) 539.50 (3)
OFFER PRICE (QTY) 544.00 (51)
VOLUME 17164
TODAY'S LOW / HIGH ( )530.65 554.00
52 WK LOW / HIGH ( )145.35 630
NSE541.808.25 (+1.55 %)
PREV CLOSE( ) 533.55
OPEN PRICE ( ) 543.90
BID PRICE (QTY) 541.05 (11)
OFFER PRICE (QTY) 541.80 (15)
VOLUME 188377
TODAY'S LOW / HIGH( ) 540.00 554.00
52 WK LOW / HIGH ( )145.15 630
ChairmanHabil Khorakiwala
Managing DirectorMurtaza Khorakiwala
Company SecretaryRashmi Mamtura
Executive DirectorHuzaifa Khorakiwala
Non Executive Independent DirectorAman Mehta
Sanjaya Baru
Tasneem Mehta
Vinesh Kumar Jairath
Akhilesh Gupta
Davinder Singh Brar
Amelia Fernandes
Non Independent & Non Executive DirectorZahabiya Khorakiwala
Incorporation Year : 08-07 1999

Registered Office :

Address : D-4, M. I. D. C,Chikalthana, Chhatrapati Sambhajinagar - (Aurangabad),
Maharashtra-431006 .

Phone : 0240-6632222 / 6694444

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,Luxembourg, MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.